Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 5/20 | 0.66 |
| ▸ | AKR1B10 | O60218 | 4/20 | 0.66 |
| ▸ | AKR1B1 | P15121 | 4/20 | 0.66 |
| ▸ | MMP2 | P08253 | 6/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.66 |
| ▸ | MMP9 | P14780 | 4/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.66 |
| ▸ | CA12 | O43570 | 3/20 | 0.66 |
| ▸ | CA1 | P00915 | 3/20 | 0.66 |
| ▸ | CA2 | P00918 | 3/20 | 0.66 |
| ▸ | CA3 | P07451 | 3/20 | 0.66 |
| ▸ | CA4 | P22748 | 3/20 | 0.66 |
| ▸ | CA6 | P23280 | 3/20 | 0.66 |
| ▸ | CA5A | P35218 | 3/20 | 0.66 |
| ▸ | CA7 | P43166 | 3/20 | 0.66 |
| ▸ | CA9 | Q16790 | 3/20 | 0.66 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.66 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.66 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.66 |
| ▸ | DPP4 | P27487 | 2/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12555874 | 1.00 | AKR1C3 (0.66) | AKR1C3AKR1B10AKR1B1MMP2KDM4E | |
| SCHEMBL29395741 | 1.00 | AKR1C3 (0.66) | AKR1C3AKR1B10AKR1B1MMP2KDM4E | |
| SCHEMBL19511929 | 0.87 | AKR1C3 (0.62) | AKR1C3AKR1B10AKR1B1MMP2KDM4E | |
| SCHEMBL19511928 | 0.87 | AKR1C3 (0.62) | AKR1C3AKR1B10AKR1B1MMP2KDM4E | |
| SCHEMBL10632283 | 0.86 | AKR1C3 (0.70) | AKR1C3AKR1B10AKR1B1MMP2KDM4E | |
| SCHEMBL13663908 | 0.86 | MMP9 (0.76) | AKR1C3AKR1B10AKR1B1MMP2KDM4E | |
| SCHEMBL14389635 | 0.86 | KDM4E (0.66) | AKR1C3AKR1B10AKR1B1MMP2KDM4E | |
| SCHEMBL10898075 | 0.86 | EGFR (0.56) | AKR1C3AKR1B10AKR1B1MMP2KDM4E | |
| SCHEMBL10898081 | 0.86 | EGFR (0.56) | AKR1C3AKR1B10AKR1B1MMP2KDM4E | |
| SCHEMBL12593153 | 0.85 | IAPP (0.67) | AKR1C3AKR1B10AKR1B1MMP2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240016719-A1 | TOPICAL COMPOSITIONS AND METHODS | MARY KAY INC. | 2024-01-18 | — | — | US | disclosed |
| US-11779532-B2 | Topical compositions and methods | MARY KAY INC. (US) | 2023-10-10 | — | — | US | disclosed |
| US-20230285336-A1 | COMPOSITION FOR PREVENTION AND TREATMENT OF SKIN DISEASES CAUSED BY GENETIC MUTATION COMPRISING FERULIC ACID AND ANALOGS THEREOF | UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) | 2023-09-14 | — | — | US | disclosed |
| CN-114105807-B | Hydroxycyclohexanamide compound and preparation method and application thereof | 暨南大学 | 2023-08-18 | — | — | CN | disclosed |
| US-11717549-B2 | Steviol glycoside solubility enhancers | CARGILL, INCORPORATED (US) | 2023-08-08 | — | — | US | disclosed |
| US-20230226028-A1 | ANTIVIRAL THERAPY WITH IMIQUIMOD AND COCRYSTALS THEREOF | CELISTA PHARMACEUTICALS LLC | 2023-07-20 | — | — | US | disclosed |
| US-20230133290-A1 | ACTIVE MIXURE | SYMRISE AG (DE) | 2023-05-04 | — | — | US | disclosed |
| CN-114105807-A | Hydroxycyclohexane diamide compound and preparation method and application thereof | 暨南大学 | 2022-03-01 | — | — | CN | disclosed |
| US-20180216063-A1 | THREE-DIMENSIONAL VASCULAR NETWORK ASSEMBLY FROM INDUCED PLURIPOTENT STEM CELLS | THE JOHNS HOPKINS UNIVERSITY | 2018-08-02 | — | — | US | disclosed |
| US-20180200224-A1 | Antiviral Activity from Medicinal Mushrooms and Their Active Constituents | TURTLE BEAR HOLDINGS, LLC | 2018-07-19 | — | — | US | disclosed |
| WO-2013034746-A1 | ANTI-INFLAMMATORY COMPOSITIONS COMPRISING MALVIDIN - 3 - O - BETA-GLUCOSIDE AND A PROPOLIS EXTRACT | Université Bordeaux Segalen (FR) | 2013-03-14 | — | — | WO | disclosed |
| US-20120276596-A1 | MODIFIED BIOMATERIAL, USES THEREOF AND MODIFICATION METHODS | TEKNOLOGIAN TUTKIMUSKESKUS VTT (FI) | 2012-11-01 | — | — | US | disclosed |
| US-20120276596-A1 | MODIFIED BIOMATERIAL, USES THEREOF AND MODIFICATION METHODS | TEKNOLOGIAN TUTKIMUSKESKUS VTT (FI) | 2012-11-01 | — | — | US | disclosed |
| US-20120138789-A1 | Phosphonium-Based Ionic Liquids and Uses | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2012-06-07 | — | — | US | disclosed |
| US-20120094973-A1 | CATECHOL-BASED DERIVATIVES FOR TREATING OR PREVENTING DIABETICS | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-04-19 | — | — | US | disclosed |
| US-20120052757-A1 | MOLECULARLY IMPRINTED POLYMERS | MONASH UNIVERSITY (AU) | 2012-03-01 | — | — | US | disclosed |
| US-20110224260-A1 | CATECHOL-BASED DERIVATIVES FOR TREATING OR PREVENTING DIABETICS | NATIONAL TAIWAN UNIVERSITY (TW) | 2011-09-15 | — | — | US | disclosed |
| US-20110159121-A1 | METHODS AND COMPOSITIONS FOR IDENTIFYING, PRODUCING AND USING PLANT-DERIVED PRODUCTS FOR MODULATING CELL FUNCTION AND AGING | LifeSpan Extension, LLC | 2011-06-30 | — | — | US | disclosed |
| US-20110144143-A1 | PHARMACEUTICAL COMPOSITION CONTAINING FERULIC ACID AND MATRINE COMPOUNDS, THE PREPARATION AND THE USE THEREOF | QINGDAO QIYUAN BIO-TECHNOLOGIES CO., LTD. (CN) | 2011-06-16 | — | — | US | disclosed |
| US-20070282422-A1 | Medical devices and methods for local delivery of elastin-stabilizing compounds | COOK INCORPORATED | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (14 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240016719-A1 | TOPICAL COMPOSITIONS AND METHODS | CUTA, TYR, TPH1 | AKR1C3 2228/4885AKR1B10 2363/4885AKR1B1 2296/4885 |
| US-20120094973-A1 | CATECHOL-BASED DERIVATIVES FOR TREATING OR PREVENTING DIABETICS | SLC5A2, SLC5A1, SLC2A8 | AKR1C3 949/4885AKR1B10 582/4885AKR1B1 637/4885 |
| US-20230285336-A1 | COMPOSITION FOR PREVENTION AND TREATMENT OF SKIN DISEASES CAUSED BY GENETIC MUTATION COMPRISING FERULIC ACID AND ANALOGS THEREOF | BRCA1, VHL, TSG101 | AKR1C3 648/4885AKR1B10 1004/4885AKR1B1 732/4885 |
| US-20110224260-A1 | CATECHOL-BASED DERIVATIVES FOR TREATING OR PREVENTING DIABETICS | SLC5A2, SLC5A1, SLC2A8 | AKR1C3 949/4885AKR1B10 582/4885AKR1B1 637/4885 |
| US-20120052757-A1 | MOLECULARLY IMPRINTED POLYMERS | IPMK, MPI, PIM3 | AKR1C3 1493/4885AKR1B10 1477/4885AKR1B1 1341/4885 |
| US-20230133290-A1 | ACTIVE MIXURE | GUSB, MMP8, IDUA | AKR1C3 3248/4885AKR1B10 2344/4885AKR1B1 3412/4885 |
| US-11717549-B2 | Steviol glycoside solubility enhancers | SI, TAS2R7, TAS2R31 | AKR1C3 3982/4885AKR1B10 1821/4885AKR1B1 3071/4885 |
| US-20180216063-A1 | THREE-DIMENSIONAL VASCULAR NETWORK ASSEMBLY FROM INDUCED PLURIPOTENT STEM CELLS | HIF1A, EGLN3, EPAS1 | AKR1C3 4496/4885AKR1B10 4805/4885AKR1B1 4757/4885 |
| US-20230226028-A1 | ANTIVIRAL THERAPY WITH IMIQUIMOD AND COCRYSTALS THEREOF | ME1, CS, ME2 | AKR1C3 368/4885AKR1B10 1213/4885AKR1B1 605/4885 |
| US-11779532-B2 | Topical compositions and methods | RARA, TYR, PPARA | AKR1C3 3934/4885AKR1B10 4722/4885AKR1B1 4251/4885 |
| US-20180200224-A1 | Antiviral Activity from Medicinal Mushrooms and Their Active Constituents | MAVS, STING1, ZC3HAV1 | AKR1C3 4591/4885AKR1B10 4417/4885AKR1B1 4496/4885 |
| US-20110159121-A1 | METHODS AND COMPOSITIONS FOR IDENTIFYING, PRODUCING AND USING PLANT-DERIVED PRODUCTS FOR MODULATING CELL FUNCTION AND AGING | TFAM, POLRMT, CS | AKR1C3 3054/4885AKR1B10 3092/4885AKR1B1 2767/4885 |
| US-20120138789-A1 | Phosphonium-Based Ionic Liquids and Uses | SRMS, PHOSPHO1, TRMT1L | AKR1C3 4845/4885AKR1B10 4415/4885AKR1B1 4820/4885 |
| US-20110144143-A1 | PHARMACEUTICAL COMPOSITION CONTAINING FERULIC ACID AND MATRINE COMPOUNDS, THE PREPARATION AND THE USE THEREOF | MATR3, FER, FIBP | AKR1C3 2013/4885AKR1B10 2165/4885AKR1B1 2448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.